HRTX FY 2009 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$147M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+241.7% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$10M-812.2% margin

Net Income

-$10M-795.2% margin

EPS (Diluted)

$-6.15

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$9M

Total Liabilities

$2M

Stockholders' Equity

$7M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$369,000	+241.7%
Gross Profit	$1M	$369,000	+241.7%
Operating Income	-$10M	-$23M	+56.3%
Net Income	-$10M	-$23M	+56.6%